Development Status

【Ophthalmology Area】

Development Code	Indication	Market	Pre-clinical test	Clinical test	Apply-approve	On the Market	Progress Status
HLCR011	Wet AMD	Japan					Joint development with Sumitomo Dainippon Pharma Undergoing preparation for clinical trial

【Liver Disease】

Development Code	Indication	Market	Pre-clinical test	Clinical test	Apply-approve	On the Market	Progress Status
HLCL041	Metabolic Liver Disease	Japan					Joint research with Yokohama City University

【Immuno Oncology】

Development Code	Indication	Market	Pre-clinical test	Clinical test	Apply-approve	On the Market	Progress Status
HLCN061	Solid Tumors	Japan					Healios is promoting R&D

Development Code	Indication	Market	Pre-clinical test	Phase I Trial	Phase II Trial	Phase III Trial	Apply-approve	On the Market	Progress Status
HLCN061	Solid Tumors	US							Healios is promoting R&D

1. NK (Natural killer) cells : NK cells are a subset of lymphocytes, a type of white blood cell. NK cells play a central role in a cell mediated defense system that human bodies naturally have, and attack cancer cells and virus-infected cells.